Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
(Deleted maintenance CTA clinically feasible Profile 2023-02-16) |
|||
Line 27: | Line 27: | ||
| [[Media:QIBA CTA Comments all resolved.xlsx| Public Comment Resolutions 2020-03-12]] | | [[Media:QIBA CTA Comments all resolved.xlsx| Public Comment Resolutions 2020-03-12]] | ||
|- | |- | ||
− | | [[Media: | + | | [[Media:Atherosclerosis Biomarkers Profile 2023Mar28.pdf| CT Atherosclerosis 2023-03-28]] |
− | |||
− | |||
− | |||
− | |||
− | |||
| Clinically Feasible | | Clinically Feasible | ||
| TBD | | TBD | ||
− | | [[Media: | + | | [[Media:CTA Profile Clinically Feasible Comment Resolutions.2023Mar28.pdf|Clinically Feasible Comment Resolutions 2023-03-28]] |
|- | |- | ||
| [[Media:QIBA CT Lung Density Profile 090420-clean.pdf| CT Lung Density 2020-09-04]] | | [[Media:QIBA CT Lung Density Profile 090420-clean.pdf| CT Lung Density 2020-09-04]] |
Revision as of 17:26, 29 March 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.